/Danaher%20Corp_%20logo%20on%20vial-by%20Melnilov%20Dmitriy%20via%20Shutterstock.jpg)
Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. The company is valued at $142.3 billion by market cap. The leading global life sciences and diagnostics innovator is expected to announce its fiscal second-quarter earnings for 2025before the market opens on Tuesday, Jul. 22.
Ahead of the event, analysts expect DHR to report a profit of $1.64 per share on a diluted basis, down 4.7% from $1.72 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.